Hikma Pharmaceuticals PLC News - Mubasher Info
KSA
Mubasher TV
 Contact Us Advertising   العربية
KSA
TDWL Closed
02 April 07:26 PM

Hikma Pharmaceuticals PLC (HIK)

Last update: 20 November 2007 01:44 PM market time.
19.20
-1.25
-6.11%
Open 19.90
Previous Close 20.45
High 19.90
Low 19.20
Stock Statistics
Volume 200
Turnover 3,910.00
All data are 15 minutes late during market session

News

Hikma Pharmaceuticals signed non-binding deal to acquire GSK Egypt
27 January 2021 00:20 PM Hikma Pharmaceuticals allowed to conduct due diligence on GSK Egypt
Cairo – Mubasher: The board of directors of Glaxo SmithKline (GSK Egypt) agreed to allow Hikma Pharmaceuticals Plc to conduct due diligence on the company, according to a bourse disclosure on Wednesday. On Tuesday, the company said that its …
Mergers and Acquisitions
GSK Egypt reported net profits of EGP 101.41 million in nine months
26 January 2021 01:57 PM Hikma Pharmaceuticals to acquire majority stake in GSK Egypt
Cairo – Mubasher: Galxo Group Limited signed a non-binding term sheet with Hikma Pharmaceuticals Plc for the potential sale of its entire stake of 91.2% in Glaxo SmithKline (GSK Egypt). The acquisition will be implemented by submitting a mandatory …
Mergers and Acquisitions
The company expect growth in the pharmaceutical sector's revenues
12 July 2020 03:24 PM Hikma Pharmaceuticals issues $500m Eurobonds
UAE - Mubasher: Hikma Pharmaceuticals, listed on Nasdaq Dubai and the London Stock Exchange, issued five-year Eurobonds worth $500 million with an annual interest rate of 3.25%. The pharmaceutical sector's revenues are expected to grow in 2020, …
Bonds
Hikma will distribute eleven of Chiesi’s leading products in Egypt
14 January 2020 00:30 PM Hikma Pharmaceuticals inks deal to distribute Chiesi’s products in Egypt
Cairo - Mubasher: Hikma Pharmaceuticals, a global company with local presence in the US, the MENA region, and Europe, has penned a licensing and distribution agreement with Italy-headquartered Chiesi Farmaceutici, an international research-focused …
Companies Investments
Hikma Pharmaceuticals’ investments in the Egyptian market range between $250 million and $300 million
17 September 2018 05:54 PM Hikma Pharmaceuticals’ Egypt investments near $300m – MD
By: Ahmed Allam Cairo – Mubasher: Hikma Pharmaceuticals’ investments in the Egyptian market range between $250 million and $300 million, the firm’s managing director in Egypt said on Monday. Speaking on the sidelines of a press conference …
Companies Investments
30 October 2014 00:01 PM U.S. FDA sends warning letter to Hikma
In a statement issued by Hikma Pharmaceuticals to Nasdaq Dubai, the Company announced receiving a warning letter from the U.S. Food and Drug Administration (FDA) on October 23, 2014 regarding environmental monitoring and …
Company News